Olfera


Developer of an olfactory-route platform to enable direct brain delivery of therapeutics for neurological conditions. The organization describes capabilities in drug discovery, screening, medicinal chemistry, and formulation to convert existing and experimental neurological drugs into intranasal, non‑invasive treatments that bypass the blood–brain barrier.

Industries

Biotechnology
Medical
Medical Device
Pharmaceutical
Biotechnology Research

Nr. of Employees

small (1-50)

Olfera

Mountain View, California, United States


Patents

Olfactory delivery scaffold compounds

US-12642855-B2

View Details

Olfactory delivery scaffolds using antisense oligonucleotides and methods for making and using same

US-12629423-B2

View Details

Services

Platform-based screening and chemistry to discover or optimize molecules for delivery to the brain via the olfactory route.

Formulation and optimization of nasal spray delivery systems intended to improve patient convenience and brain delivery.

Advisory support on translating neurological candidates to olfactory-route delivery, including screening, chemistry, and formulation considerations.

Expertise Areas

  • Olfactory-mediated brain delivery
  • Neurological therapeutic development
  • Drug repurposing and optimization
  • Nasal formulation development
  • Show More (2)

Key Technologies

  • Intranasal delivery
  • Nasal spray formulation
  • Drug screening assays
  • Medicinal chemistry
  • Show More (2)

News & Updates

Default blog post found on the site (WordPress placeholder).


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.